MEDtalk: Background and study design of the SPARTAN study

Best Practice Nordic | Jun 2020 | ASCO20 Virtual |

Eric J. Small, MD and principal investigator of the SPARTAN study explains the background and study design of the SPARTAN study, where the efficiency and safety of apalutamide for patients with nonmetastatic castration-resistant prostate cancer (nmCRPC) was investigated.